Melanoma (May 2014) | Targeted Therapies: Melanoma

Managing Toxicities in Melanoma

August 30, 2014

Clinical Articles

Recent advances in immunotherapy and in agents that target specific genetic mutations in the mitogen-activated protein kinase (MAPK) pathway have led to dramatic improvements in outcomes for patients with advanced cutaneous melanoma.

Risk Factors and Trends in Melanoma

August 28, 2014

Clinical Articles

Risk factors for contracting melanoma are complex and can include environmental exposure and an individual’s genetic susceptibility, but people at highest risk are those with a personal or family history of melanoma and those with large, atypical, and/or multiple (more than 50) nevi.

Targeted Treatments for Melanoma

May 07, 2014

Clinical Articles

Many patients with melanoma are diagnosed with unresectable stage III or IV disease that requires systemic treatment. Treatment of melanoma depends largely on the stage at diagnosis.